Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The consensus price target hints at a 31.1% upside potential for Masimo (MASI). While empirical research shows that this ...

Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.

Masimo Corp. has urged a California federal judge to reject Apple’s bid to erase a US$634 million patent-infringement verdict ...

Masimo Corp. urged a California federal judge to reject Apple Inc.’s bid to erase a $634 million patent-infringement verdict over Apple Watch heart-rate alerts, arguing trial evidence supported the ...

Clairity , a U.S.-based medical technology company advancing AI-powered breast cancer risk assessment, today announced that its founder, Connie Lehman, MD, PhD, has assumed the role of Chief Executive ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IDEAYA Biosciences (IDYA – Research Report), Masimo (MASI – Research Report) a ...

Investigation stems from a complaint filed by Texas-based company UnaliWear, and targets several other wearables. Here are ...

Fall detection wearable specialist UnaliWear says that Apple Watch and just about every other smartwatch ever made infringes ...

MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core ...

In a report released today, Vik Chopra from Wells Fargo maintained a Buy rating on Masimo, with a price target of $190.00. According to TipRanks, Chopra is a 3-star analyst with an average return of 6 ...